Article info
PDFResponse
‘Serious’ factor—a relevant starting point for further debate: a response
- Correspondence to Erika Kleiderman, Centre of Genomics and Policy, McGill University, Montreal, Quebec H3A 0G4, Canada; erika.kleiderman{at}mcgill.ca
Citation
‘Serious’ factor—a relevant starting point for further debate: a response
Publication history
- Received September 6, 2019
- Revised October 7, 2019
- Accepted October 23, 2019
- First published November 6, 2019.
Online issue publication
February 07, 2020
Article Versions
- Previous version (6 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- The ‘ serious ’ factor in germline modification
- Is it ethical to provide IVF add - ons when there is no evidence of a benefit if the patient requests it
- Clinical applications of preimplantation genetic testing
- Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies
- Assisted reproductive technologies do not enhance the variability of DNA methylation imprints in human
- Fertility preservation in women with early - stage gynecologic cancer: optimizing oncologic and reproductive outcomes
- Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study
- The epigenetic imprinting defect of patients with Beckwith — Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region
- Assessing cardiovascular remodelling in fetuses and infants conceived by assisted reproductive technologies: a prospective observational cohort study protocol
- Maternal history of miscarriages and measures of fertility in relation to childhood asthma